In-article:

Neurocrine Biosciences, Inc.: Goldman Sachs Still Positive







Marketzone with MT Newswires 2022

All the news about NEUROCRINE BIOSCIENCES, INC.

Analyst Recommendations for NEUROCRINE BIOSCIENCES, INC.

2022 turnover 1,421M

1,399M
2022 net result 178M

175M
trso. net 2022 938M

923M
PER 202251.0x
2022 return
Capitalization 9,944M
9,944M
9,791M
VE / CA 20226.34x
VE / CA 20235.35x
Number of employees1,100
Floating98.2%

Chart NEUROCRINE BIOSCIENCES, INC.


Hard :

Period:




Neurocrine Biosciences, Inc. : Neurocrine Biosciences, Inc. Technical Analysis Chart |  Market area

Trends Technical Analysis NEUROCRINE BIOSCIENCES, INC.

Short termMiddle termLong term
TrendsbullishbullishNeutral

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts25
Last Closing Price$104.04
Average price target$114.45
Deviation / Average Target10.0%

Officers and Directors




Source link -88